medigraphic.com
SPANISH

Revista Médica del Instituto Mexicano del Seguro Social

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number S1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2015; 53 (S1)

The cord blood bank at the Instituto Mexicano del Seguro Social

Peñaflor-Juárez K, Guillén-Chan SM, Romero-Juárez Y, Luna-Bautista F, Franco-Gutiérrez E, Arellano- Ocampo JS, Ibáñez-Sánchez R, Domínguez-Contreras ML, Guerra-Márquez Á
Full text How to cite this article

Language: Spanish
References: 19
Page: 94-99
PDF size: 73.15 Kb.


Key words:

Cord blood banking, Transplantation, Hematopoietic stem cells.

ABSTRACT

Background: Hematopoietic stem cells have been used for over 50 years in the treatment of diverse diseases. Umbilical cord blood (UCB) has proved to be a viable source of hematopoietic stem cells for transplantation purposes. The aim was to report the contribution of the umbilical cord blood bank over the past 9 years, in the treatment of various diseases.
Methods: Since 2005 the number of units of blood from the umbilical cord and their use for transplantation in diverse disease were analyzed. A selection of volunteer pregnant women in labor was performed. Umbilical cord blood was obtained from them, which underwent processing, cryopreservation and validation, as well as compatibility test before using for transplantation.
Results: Ten thousand and ninety nine candidates to donation were assessed, from whom 2481 unit of UCB were collected. Of these, 893 unit were processed and cryopreserved for transplantation. In 65 % of cases there was histocompatibility between the cord cell and the receptors. Transplantation was done in 87 patients, 67 % had hematologic neoplasias, who have received 140 units of UCB in 102 transplants. This Bank of UCB ranks second in the world in productivity according to the rate of utility of units in transplantation (3.3 %).
Conclusions: Our bank of UCB has been able to develop a cell line (hematopoietic stem cells) with international quality standards and has been benefi cial for patients served by our institution with need of a transplant mainly in hemato-oncologic patients.


REFERENCES

  1. Starzl TE. History of Clinical Transplantation. World J Surg 2000;24(7):759-82.

  2. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potencial source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989;86:3828-32.

  3. Gluckman E, Broxmeyer HE, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi´s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Eng J Med 1989; 321:1174-78.

  4. Rubinstein P, Dobrila L, Richard E, Rosenfi eld RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119-22.

  5. Gluckman EG, Rocha V, Chastang C. Use of Cord Blood for Banking and Transplant. The Oncologist 1997;2:340-3.

  6. Novelo-Garza BA, Benítez-Arvizu G, Cortés-Márquez S, Sánchez-Cañas JA, Franco-Gutiérrez E. ¿Es importante el volumen en la recolección de sangre de cordón umbilical?. Rev Med Inst Mex Seguro Soc 2006;44(Supl 2):107-10.

  7. Benítez-Arvizu G, Martínez S, Guerra A, Luna F, Romero Y, Novelo-Garza BA. Dos técnicas para reducir el volumen de sangre obtenida de cordón umbilical. Rev Med Inst Mex Seguro Soc 2010;48(4):443-6.

  8. Benítez-Arvizu G, Ibarra-Pichardo Y, Guerra-Márquez A, Malagón-Martínez A. Una cosecha adecuada de células nucleadas totales en sangre de cordón umbilical. ¿Qué valorar? Rev Mex Med Tran 2013;6(1):7-11.

  9. Novelo-Garza B, Limón-Flores A, Guerra-Márquez A, Bautista-Luna F, Juan-Shum L et al. Establishing a cord blood banking and transplantation program in Mexico: a single institution experience. Transfusion 2008;48:228-36.

  10. Guerra-Márquez A, Novelo-Garza B, Malagón-Martínez A, Limón-Flores A, Luna-Bautista F et al. Cord blood banking and transplantation at the Mexican Institute of Social Security: the fi rst 5 years. Transfusion 2011;51:328-32.

  11. Boo M. Public cord blood banking may play an important role in the emergence of unrelated transplant in developing countries. Transfusion 2008;48; 207-8.

  12. Sniecinski I. Cord Blood Banking in Developing Countries. En: Broxmeyer HE ed. Cord Blood: Biology, Transplantation, Banking, and Regulation. Bethesda, MD: AABB Press, 2011. p. 647-62.

  13. World Marrow Donor Association. Unrelated Cord Blood Banks/Registries Annual Report 2012. 14th ed. Leiden, Netherlands. World Marrow Donor Association, 2013.

  14. Donaldson C, Buchanan R, Webster J, et al. Development of a district Cord Blood Bank: a model for cord blood banking in the National Health Service. Bone Marrow Transplant 2000;25:899-905.

  15. Armitage S, Warwick R, Fehily D, et al. Cord blood banking in London: the fi rst 1000 collections. Bone Marrow Transplant 1999;24:139-45.

  16. Lauber S, Latta M, Klüter H, et al. The Mannheim Cord Blood Bank: Experiences and Perspectives for the Future. Transfus Med Hemother 2010;37: 90-7.

  17. Liu J, He J, Chen S, et al. Cord Blood Banking and Transplantation in China: A Ten Years Experience of a Single Public Bank. Transfus Med Hemother 2012; 39:23-7.

  18. Viswanathan C, Kabra P, Nazareth V, et al. India´s fi rst public cord blood repository – looking back and moving forward. Indian J Hematol Transfus 2009;25(3):111-7.

  19. Mironov V, Visconti RP, Markwald RR. What is regenerative medicine? The emergence of applied stem cell and development biology. Expert Opin Biol Ther 2004;4(6):773-81.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Inst Mex Seguro Soc. 2015;53